BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38542454)

  • 1. Understanding the Term "Necrobiosis".
    Gupta S; Joshi R; Chikhalkar S; Kharkar V
    Indian Dermatol Online J; 2024; 15(3):552-555. PubMed ID: 38845653
    [No Abstract]   [Full Text] [Related]  

  • 2. A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.
    Naumowicz M; Modzelewski S; Macko A; Łuniewski B; Baran A; Flisiak I
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options.
    Reid SD; Ladizinski B; Lee K; Baibergenova A; Alavi A
    J Am Acad Dermatol; 2013 Nov; 69(5):783-791. PubMed ID: 23969033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature.
    Suárez-Amor O; Pérez-Bustillo A; Ruiz-González I; Rodríguez-Prieto MA
    Dermatology; 2010; 221(2):117-21. PubMed ID: 20805688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-resistant ulcerative necrobiosis lipoidica in a diabetic patient responsive to ustekinumab.
    Pourang A; Sivamani RK
    Dermatol Online J; 2019 Aug; 25(8):. PubMed ID: 31553866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerating necrobiosis lipoidica resolving in response to cyclosporine-A.
    Smith K
    Dermatol Online J; 1997 Mar; 3(1):2. PubMed ID: 9141363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].
    Leister L; Körber A; Dissemond J
    Hautarzt; 2013 Jul; 64(7):509-11. PubMed ID: 23595890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for necrobiosis lipoidica: a systematic review.
    Nihal A; Caplan AS; Rosenbach M; Damsky W; Mangold AR; Shields BE
    Int J Dermatol; 2023 Dec; 62(12):1529-1537. PubMed ID: 37772666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK-STAT inhibitors in Immune mediated diseases: An Overview.
    Shah RJ; Banerjee S; Raychaudhuri S; Raychaudhuri SP
    Indian J Dermatol Venereol Leprol; 2023; 89(5):691-699. PubMed ID: 37609730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrobiosis lipoidica in childhood: a review of literature with emphasis on therapy.
    Schiefer-Niederkorn A; Sadoghi B; Binder B
    J Dtsch Dermatol Ges; 2023 Oct; 21(10):1120-1129. PubMed ID: 37401158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of necrobiosis lipoidica with secukinumab (Cosentyx): a case series.
    Gibson RS; Salian P; Beckles A; Stavert R; Tahan S; Kimball AB; Porter ML
    Int J Dermatol; 2023 Sep; 62(9):1198-1201. PubMed ID: 37392065
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidative stress and metabolic syndrome in acne vulgaris: Pathogenetic connections and potential role of dietary supplements and phytochemicals.
    Bungau AF; Radu AF; Bungau SG; Vesa CM; Tit DM; Endres LM
    Biomed Pharmacother; 2023 Aug; 164():115003. PubMed ID: 37315434
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.